Will Altria Buy Out Cronos (TSX:CRON) Stock?

Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…

Read More

Why Did HEXO’s Stock Price Fall 26% on Wednesday?

Canadian marijuana producer HEXO‘s (TSX:HEXO)(NYSE:HEXO) stock price fell more than 26% on Wednesday as investors reacted to a news release the company issued that morning. What happened? HEXO announced a $40 million underwritten public offering of its common stock early on Wednesday. The latest offering was priced at $0.77 per share. This is a 20% discount to the previous day’s closing…

Read More

Canndescent Raises $27.50 Million in Series C Funding Led By Green Acre Capital

Canndescent is engaged as a California-based ultra-premium cannabis company. The cannabis company became the first in the world to effectively move away from traditional marijuana strains in favor of “effects-based cannabis.” Among the various effects offered include: Calm, Cruise, Create, Connect, and Charge. Canndescent became California’s top-selling luxury cannabis flower brand in 2017 and has since expanded its product offering…

Read More